{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:52:48Z","timestamp":1791903168949,"version":"4.3.4"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.pain.2011.01.040","type":"journal-article","created":{"date-parts":[[2011,3,13]],"date-time":"2011-03-13T04:37:41Z","timestamp":1299991061000},"page":"1139-1145","source":"Crossref","is-referenced-by-count":178,"title":["Influence from genetic variability on opioid use for cancer pain: A European genetic association study of 2294 cancer pain patients"],"prefix":"10.1097","volume":"152","author":[{"given":"P.","family":"Klepstad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Fladvad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Skorpen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Bjordal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Caraceni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Dale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kloke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Lundstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Maltoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Radbruch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Sabatowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Sigurdardottir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Strasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. M.","family":"Fayers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Kaasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"RU5-28-20210126","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/nn1916","article-title":"Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors.","volume":"10","author":"Agarwal","year":"2007","journal-title":"Nat Neurosci"},{"key":"R15-28-20210126","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3102\/10769986025001060","article-title":"On the adaptive control of the false discovery rate in multiple testing with independent statistics.","volume":"25","author":"Benjamini","year":"2000","journal-title":"J Educ Behav Stat"},{"key":"R20-28-20210126","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/sj.clpt.6100385","article-title":"Association of ABCB1MDR1 and OPRM1 gene polymorphisms with morphine pain relief.","volume":"83","author":"Campa","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"R25-28-20210126","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1200\/JCO.2001.19.9.2542","article-title":"Expert Working Group of the European Association of Palliative Care Network. Strategies to manage the adverse effects of oral morphine: an evidence-based report.","volume":"19","author":"Cherny","year":"2001","journal-title":"J Clin Oncol"},{"key":"RU30-28-20210126","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s002130050999","article-title":"Selective attenuation of the antinociceptive effects of mu opioids by the putative dopamine D3 agonist 7-OH-DPAT.","volume":"144","author":"Cook","year":"1999","journal-title":"Psychopharmacology"},{"key":"RU35-28-20210126","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1016\/j.pnpbp.2008.07.009","article-title":"Association of dopamine and opioid receptor genetic polymorphisms with response to methadone maintenance treatment.","volume":"32","author":"Crettol","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R40-28-20210126","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0304-3959(83)90143-4","article-title":"Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases.","volume":"17","author":"Daut","year":"1983","journal-title":"Pain"},{"key":"RU45-28-20210126","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/ajmg.b.30324","article-title":"Three major haplotypes of the beta2 adrenergic receptor define psychological profile, blood pressure, and the risk for development of a common musceloskeletal pain disorder.","volume":"141","author":"Diatchenko","year":"2006","journal-title":"Am J Med Genet B Neuropsychatr Genet"},{"key":"R50-28-20210126","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jpainsymman.2004.05.008","article-title":"A multicenter study of the revised Edmonton staging system for classifying cancer pain in advanced cancer patients.","volume":"29","author":"Fainsinger","year":"2005","journal-title":"J Pain Symptom Manage"},{"key":"R55-28-20210126","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"Mini-mental state. A practical method for grading the cognitive state of patients for the clinician.","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"RU60-28-20210126","first-page":"1285","article-title":"Role of mPKCI, a novel mu-opioid receptor interactive protein, in receptor desensitization, phosphorylation, and morphine-induced analgesia.","volume":"66","author":"Guang","year":"2004","journal-title":"Mol Pharmacol"},{"key":"R65-28-20210126","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00125817-200203000-00002","article-title":"A comprehensive review of genetic association studies.","volume":"4","author":"Hirschhorn","year":"2002","journal-title":"Genet Med"},{"key":"R70-28-20210126","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/1097-0142(194811)1:4<634::AID-CNCR2820010410>3.0.CO;2-L","article-title":"The use of nitrogen mustards in the palliative treatment of carcinoma.","volume":"1","author":"Karnofsky","year":"1948","journal-title":"Cancer"},{"key":"RU75-28-20210126","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.pain.2006.11.015","article-title":"Mechanical, thermal and formalin-induced nociception is differentially altered in 5-HT1A, 5-HT1B, 5-HT3A and 5-HTT knock-out male mice.","volume":"130","author":"Kayser","year":"2007","journal-title":"Pain"},{"key":"RU80-28-20210126","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.pain.2004.02.027","article-title":"Genetic influence on variability in human acute experimental pain sensitivity associated with gender, ethnicity and psychological temperament.","volume":"109","author":"Kim","year":"2004","journal-title":"Pain"},{"key":"R85-28-20210126","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.jpain.2009.04.001","article-title":"Genetic contributions to clinical pain and analgesia: avoiding pitfalls in genetic research.","volume":"10","author":"Kim","year":"2009","journal-title":"J Pain"},{"key":"RU90-28-20210126","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.pain.2005.04.014","article-title":"Role of NK-1 neurotransmission in opioid-induced hyperalgesia.","volume":"116","author":"King","year":"2005","journal-title":"Pain"},{"key":"R95-28-20210126","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1191\/0269216305pm1054oa","article-title":"Research Steering Committee of the EAPC. Pain and pain treatments in European palliative care units. A cross sectional survey from the European Association for Palliative Care Research Network.","volume":"19","author":"Klepstad","year":"2005","journal-title":"Palliat Med"},{"key":"R100-28-20210126","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1111\/j.1399-6576.2004.00517.x","article-title":"The 118 A G polymorphism in the human mu-opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease.","volume":"48","author":"Klepstad","year":"2004","journal-title":"Acta Anaesthesiol Scand"},{"key":"RU115-28-20210126","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.neuropharm.2003.11.024","article-title":"Deletion of guanine nucleotide binding protein alpha z subunit in mice induces a gene dose dependent tolerance to morphine.","volume":"46","author":"Leck","year":"2004","journal-title":"Neuropharmacology"},{"key":"R120-28-20210126","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/clpt.2008.103","article-title":"The consequence of concomitantly present functional genetic variants for the identification of functional genotype-phenotype associations in pain.","volume":"85","author":"Lotsch","year":"2009","journal-title":"Clin Pharmacol Ther"},{"key":"R125-28-20210126","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00008571-200201000-00002","article-title":"The polymorphism A118G of the human mu-opioid receptor gene decreases the pupil constrictory effect of morphine-6-glucuronide but not that of morphine.","volume":"12","author":"Lotsch","year":"2002","journal-title":"Pharmacogenetics"},{"key":"RU130-28-20210126","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pain.2009.10.021","article-title":"A GTP cyclohydrolase 1 genetic variant delays cancer pain.","volume":"148","author":"Lotsch","year":"2010","journal-title":"Pain"},{"key":"R135-28-20210126","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.tips.2010.04.002","article-title":"A critical appraisal of human geotyping for pain therapy.","volume":"31","author":"Lotsch","year":"2010","journal-title":"Trends Pharmacol Sci"},{"key":"RU140-28-20210126","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0014-2999(00)00060-1","article-title":"Role of histamine H(1) receptor in pain perception: a study of the receptor gene konck-out mouse.","volume":"391","author":"Mobarakeh","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"R145-28-20210126","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1136\/jmg.2004.027698","article-title":"Melanonocortin-1 receptor gene variants affect pain and mu-opioid analgesia in mice and humans.","volume":"42","author":"Mogil","year":"2005","journal-title":"J Med Genet"},{"key":"R150-28-20210126","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.pain.2009.07.023","article-title":"Are we getting anywhere with human pain genetics?","volume":"146","author":"Mogil","year":"2009","journal-title":"Pain"},{"key":"R155-28-20210126","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/01.fpc.0000220566.90466.a2","article-title":"The mu-opioid receptor gene polymorphism 118A G depletes alfentanil-induced analgesia and protects against respiratory depression in homozygous carriers.","volume":"16","author":"Oertel","year":"2006","journal-title":"Pharmacogenet Genomics"},{"key":"R160-28-20210126","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.pain.2005.03.032","article-title":"The Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene may influence morphine requirements in cancer pain patients.","volume":"116","author":"Rakvag","year":"2005","journal-title":"Pain"},{"key":"R165-28-20210126","doi-asserted-by":"crossref","first-page":"10811","DOI":"10.1073\/pnas.0904509106","article-title":"Functional characterization of human variants of the mu-opioid receptor gene.","volume":"106","author":"Ravindranathan","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"R170-28-20210126","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.pain.2006.10.023","article-title":"Exploring joints effects of genes and the clinical efficacy of morphine for cancer pain: OPRM1 and COMT gene.","volume":"130","author":"Reyes-Gibby","year":"2007","journal-title":"Pain"},{"key":"R175-28-20210126","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/cncr.23292","article-title":"Genetic variation and response to morphine in cancer patients: catechol-O-methyltransferase and multi-drug resistance-1 gene polymorphisms are associated with central side-effects.","volume":"112","author":"Ross","year":"2008","journal-title":"Cancer"},{"key":"R180-28-20210126","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/sj.tpj.6500327","article-title":"Clinical response to morphine in cancer patients and genetic variation in candidate genes.","volume":"5","author":"Ross","year":"2005","journal-title":"Pharmacogenomics J"},{"key":"RU185-28-20210126","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1093\/emboj\/17.4.886","article-title":"Smadja C; Slowe S, Kitchen I, Dierich A, Le Meur M, Roques BP, Maldonado R, Kieffer BL. Disruption of the kappa-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective kappa-agonist U-50, 488H and attentuates morphine withdrawal.","volume":"17","author":"Simonin","year":"1998","journal-title":"EMBO J"},{"key":"R190-28-20210126","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/sj.clpt.6100095","article-title":"Pharmacogenetics of opioids.","volume":"81","author":"Somogyi","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"R195-28-20210126","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.pain.2009.07.013","article-title":"Meta-analysis of the relevance of the OPRM1 118AG genetic variant for pain treatment.","volume":"146","author":"Walter","year":"2009","journal-title":"Pain"},{"key":"R200-28-20210126","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.bbi.2006.10.011","article-title":"Glia as the bad guys: implications for improving clinical pain control and the clinical utility of opioids.","volume":"21","author":"Watkins","year":"2007","journal-title":"Brain Behav Immun"},{"key":"R205-28-20210126","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1126\/science.1078546","article-title":"Goldman D COMT val158 met genotype affects mu-opioid neurotransmitter responses to a pain stressor.","volume":"299","author":"Zubieta","year":"2003","journal-title":"Science"},{"key":"R210-28-20210126","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1213\/01.ANE.0000160588.32007.AD","article-title":"The role of opioid receptor internalization and beta-arrestins in the development of opioid tolerance.","volume":"101","author":"Zuo","year":"2005","journal-title":"Anesth Analg"}],"container-title":["Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006396-201105000-00028","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:46:29Z","timestamp":1786041989000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006396-201105000-00028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1016\/j.pain.2011.01.040","relation":{},"ISSN":["0304-3959"],"issn-type":[{"value":"0304-3959","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}